Table 2.
Baseline BAI and BDI associations with patient characteristics
Baseline BAI score |
Baseline BDI score |
|||
---|---|---|---|---|
Characteristic | Mean (SD) | P value | Mean (SD) | P value |
Sex* | ||||
Male | 6.92 (6.5) | .048 | 8.81 (5.4) | .739 |
Female | 11.77 (9.4) | 9.45 (7.8) | ||
Age† | ||||
rho est: | 0.017 | .901 | −0.115 | .408 |
Highest education‡ | ||||
High school | 14.1 (10.9) | .028§ | 11.91 (7.9) | .234 |
College | 6.52 (5.7) | 7.96 (5.7) | ||
Graduate school | 11.17 (8.5) | 9.25 (6.2) | ||
Ethnicity‡ | ||||
Non-Hispanic | .739 | .177 | ||
Asian | 4.06 (2.8) | 3.33 (4.1) | ||
Black | 2.00 (NA) | 1.00 (NA) | ||
Middle Eastern | 9.50 (0.7) | 15.5 (4.9) | ||
White | 9.86 (8.2) | 9.48 (6.1) | ||
Hispanic | 7.50 (11.1) | 8.33 (8.2) | ||
History of anxiety* | ||||
Yes | 16.50 (11.0) | .059 | 13.67 (7.2) | .055 |
No | 7.68 (6.8) | 8.16 (5.9) | ||
History of depression* | ||||
Yes | 15.14 (9.1) | .093 | 14.13 (4.9) | .011 |
No | 8.12 (7.7) | 8.20 (6.2) | ||
Baseline KPS‡ | ||||
80 | 13.00 (NA) | .876 | 9.67 (8.1) | .987 |
90 | 9.27 (8.5) | 9.03 (6.2) | ||
100 | 8.71 (8.0) | 9.06 (6.9) | ||
RT type* | ||||
IMRT/VMAT | 10.62 (8.6) | .026 | 9.95 (6.6) | .056 |
Protons | 5.57 (6.0) | 6.57 (5.0) | ||
Glioma* | ||||
Yes | 9.85 (8.4) | .526 | 9.63 (6.0) | .464 |
No | 8.32 (8.1) | 8.27 (7.0) | ||
Seizures* | ||||
Yes | 10.61 (8.1) | .343 | 10.91 (4.9) | .055 |
No | 8.27 (8.3) | 7.71 (7.1) | ||
Antiepileptic drugs* | ||||
Yes | 9.22 (7.7) | .702 | 9.82 (5.3) | .218 |
No | 9.08 (8.8) | 8.27 (7.4) | ||
Chemotherapy* | ||||
Yes | 9.86 (7.5) | .578 | 9.54 (5.8) | .590 |
No | 8.54 (8.8) | 8.58 (7.1) | ||
Surgery* | ||||
Yes | 8.53 (7.9) | .375 | 8.91 (6.3) | .726 |
No | 11.5 (9.4) | 9.80 (7.3) |
Abbreviations: IMRT/VMAT = intensity modulated RT/volumetric arc therapy; KPS = Karnofsky Performance Status; RT = radiation therapy; SD = standard deviation.
Two-sample t test.
Pearson correlation.
One-way analysis of variance.
Post hoc pairwise t test with Holm correction.